skip to main content

Valuing early-stage companies an art rather than a science - NZVIF

 

'Too soon to tell' is one of the main conclusions of a NZ Venture Investment Fund research reportabout the valuation of early-stage kiwi investments.

The report (find it here) byNZVIF's Chris Twiss and Carl Jones says the NZ market in too fledgling a stage, with too few exitsto really be able to read the tea leaves with regard to what the early-stage valuations should orcould be to be fair to both the company entrepreneurs and investors.

There has only been 16 exits in the 10 years worth of venture capital and angel investor punts onpromising businesses, with eight of these exits through trade or private sales, five throughliquidation and three as write offs.

This is from a data set of 186 companies invested in between 2004 and Dec. 2010, in whichapproximately $900 million of such formal investment has been made. The authors note that there isno separate data for the universally recognised group known as the 3 F's - friends, family and fools- but that they are likely to have at least matched the $475m invested by angels.

It is too difficult to draw conclusions the report says.

"There is simply not enough data yet relating to 'exit' values to enable us to analyse thecritical links between initial investment valuations, the valuations (upwards and downwards) of acompany as it progresses through various stages of development, and the ultimate value of thatcompany in terms of the final investment returns earned by investors," the authors say.

Over time, with a better dataset, especially around exits, NZVIF will have a more preciseunderstanding of these areas it says.

The report notes that worldwide, early stage investments are now taking much longer to reach a"liquidity event", and that there is a relative absence of IPO's as an exit option. Within the USmarket for example, in 2000 it took on average about 2.6 years to exit; now it is 8.7 years.

As noted by one experienced US angel investor, "Lemons rot faster than plums ripen."

NZ angel investors currently tend to have one or two early stage companies under their wing,though NZVIF expects this to develop to more of a portfolio approach.

North American research on angel investors by Prof Rob Wiltbank at Willamette University allows aconclusion to be drawn NZVIF says.

It is, "that an angel investor needs a portfolio of more than 10 early stage company investmentsto ensure success and that 15 would be preferable to maximise return expectations. Are New Zealandangels, therefore paying a premium for the one (or small handful) of deals they are typicallyinvesting in at present?"

The report notes that with only one or two investments, angels may have a poor outcome, and giveup on this type of investment altogether.

As noted in the report's introduction - "valuing these early stage companies is challenging giventheir highly uncertain nature and can definitely be viewed as an art rather than a science."

Valuing early-stage companies an art rather than a science - NZVIF

Valuing early-stage companies an art rather than a science - NZVIF
 
 
 
+ Text Size -
Do NOT follow this link or you will be banned from the site!
Original generation time 1.4149 seconds.